
Wednesday, July 03, 2024 6:21:11 PM
The investment bank said it believes Rolvedon could reach peak annual sales of around $140M in the early 2030s. It added that “long run positive traction” from products such as Rolvedon, Otrexup and Sympazan “ought to drive renewed interest from investors.”
The bank set its price target at $4.
Recent ASRT News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2025 09:14:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2025 08:05:17 PM
- Assertio Reports Fourth Quarter and Full Year 2024 Financial Results • GlobeNewswire Inc. • 03/12/2025 08:05:00 PM
- Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025 • GlobeNewswire Inc. • 03/05/2025 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 11:03:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 11:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 11:00:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 11:04:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 11:02:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 11:01:33 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 11:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2025 11:13:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2025 11:11:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2025 11:09:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2025 10:01:35 PM
- Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/03/2025 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 10:00:28 PM
- Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors • GlobeNewswire Inc. • 12/17/2024 01:30:00 PM
- Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study • GlobeNewswire Inc. • 12/13/2024 01:00:00 PM
- Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO • GlobeNewswire Inc. • 12/12/2024 01:00:00 PM
- Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer • GlobeNewswire Inc. • 12/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 01:27:46 PM
- Assertio Reports Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/11/2024 09:02:00 PM
- Assertio Provides Response to Letter from Short-seller • GlobeNewswire Inc. • 11/11/2024 12:30:00 PM
- Tesla Rises 5% Pre-Market After Surpassing $1T Market Value; U.S. Bans TSMC From Selling Advanced Chips to China • IH Market News • 11/11/2024 11:04:09 AM
FEATURED NUBURU Announces Elimination of 100% of its Long-Term Indebtedness and $5.15 Million Strategic Investment in Supply@ME Capital • Mar 19, 2025 8:53 AM
Authentic Holdings, Inc. to Acquire Movie and Television Library in an $11 Million Transaction • AHRO • Mar 19, 2025 8:30 AM
Wytec Begins Sales of Its Multi-State Government Contract for AI Gunshot Detection • WYTC • Mar 19, 2025 7:19 AM
4Cable TV International, Inc. Unleashes Bold Strategy to Maximize Shareholder Value with close to 7.8 billion Dilutive Shares Eliminated • CATV • Mar 18, 2025 1:15 PM
Omega Laboratories Reports Completion of Method Validation with Cannabix Technologies Inc. for Marijuana Breath Detection • BLOZF • Mar 18, 2025 8:36 AM
Xtreme One Entertainment Announces $1.5 Million Private Placement • XONI • Mar 18, 2025 12:00 AM